Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
iRadimedIRMD -0.08%92 Dividend Yield % is 0.90% as of Aug. 19, 2026, which is 18% above its 10-year median of 0.76. GuruFocus rates IRMD with a GF Score™ of 92/100 and a GF Value™ of $65.80 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 316 Medical Devices & Instruments companies, iRadimed ranks worse than 78.16% on this metric.
As of today (2026-08-19), the Trailing Annual Dividend Yield of iRadimed is 0.90%.
Good Sign:
iRadimed Corp stock Dividend Yield % is close to 1-year high.
The historical rank and industry rank for iRadimed's Dividend Yield % or its related term are showing as below:
IRMD'
s Dividend Yield % Range Over the Past 10 Years
Min: 0.33 Med: 0.76 Max: 1.24
Current: 0.9
During the past 13 years, the highest Dividend Yield of iRadimed was 1.24%. The lowest was 0.33%. And the median was 0.76%.
IRMD's Dividend Yield % is ranked worse than 78.16% of 316
companies
in the Medical Devices & Instruments industry
Industry Median: 1.975
vs IRMD: 0.90
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
The historical data trend for iRadimed's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IRMD vs AORT, TNDM, AVNS: Dividend Yield % Comparison
For the Medical Devices subindustry, iRadimed's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
iRadimed Dividend Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, iRadimed's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where iRadimed's Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
iRadimed Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
USD 0.200000
2026-08-14
2026-08-14
2026-08-28
Cash Dividend
quarterly
USD:USD 1.000000
USD 0.200000
2026-05-15
2026-05-15
2026-05-29
Cash Dividend
quarterly
USD:USD 1.000000
USD 0.200000
2026-02-23
2026-02-23
2026-03-06
Cash Dividend
quarterly
USD:USD 1.000000
USD 0.170000
2025-11-14
2025-11-14
2025-11-25
Cash Dividend
quarterly
USD:USD 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
iRadimed's Trailing Annual Dividend Yield (%) for Today is calculated as
Trailing Annual Dividend Yield
=
Most Recent Full Year Dividend
/
Current Share Price
=
0.77
/
87.55
=
0.88 %
Current Share Price is $87.55. iRadimed's Dividends per Share for the trailing twelve months (TTM) ended in Today is $0.77.
iRadimed's Forward Annual Dividend Yield (%) for Today is calculated as
Forward Annual Dividend Yield
=
Forward Full Year Dividend
/
Current Share Price
=
0.8
/
87.55
=
0.91 %
Current Share Price is $87.55. iRadimed's Dividends per Share for the forward twelve months is calculated as $0.2 * 4 = $0.8.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
iRadimed (IRMD) has a Dividend Yield % of 0.90% as of Aug. 19, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on iRadimed and its competitors. This is 18% above median its historical median of 0.76. Over the past decade, iRadimed's Dividend Yield % has ranged from 0.33 to 1.24. According to the industry distribution chart, iRadimed ranks #247 out of 316 companies in the Medical Devices & Instruments industry, placing it in the top 78.2%.
Is iRadimed's Dividend Yield % too high?
iRadimed's current Dividend Yield % of 0.90% is 18% above median its 10-year median of 0.76. Over the past 10 years, this metric has ranged from a low of 0.33 to a high of 1.24. The Medical Devices & Instruments industry median Dividend Yield % is 1.98. iRadimed's value of 0.90% is 54.4% below this industry median. Based on the distribution chart, iRadimed ranks #247 out of 316 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, iRadimed has a GF Score™ of 92/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does iRadimed's Dividend Yield % compare to AORT and TNDM?
According to the Medical Devices & Instruments industry distribution chart, iRadimed ranks #247 out of 316 companies for Dividend Yield %. This places iRadimed in the lower half of its industry. The industry median Dividend Yield % is 1.98. iRadimed's value of 0.90% is 54.4% below this benchmark. Historically, iRadimed's own Dividend Yield % has ranged from 0.33 to 1.24 over the past decade. While the company's 10-year median is 0.76 vs. the industry median of 1.98, iRadimed has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Medical Devices & Instruments company?
The median Dividend Yield % among Medical Devices & Instruments companies is 1.98, based on 316 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. iRadimed's current Dividend Yield % of 0.90% is 54.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on iRadimed and its competitors. For the Medical Devices & Instruments industry, the median Dividend Yield % is 1.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. iRadimed's current Dividend Yield % is 0.90%, which is 18% above median its own 10-year median of 0.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iRadimed stock overvalued right now?
Based on GuruFocus' analysis, iRadimed (IRMD) is currently considered Significantly Overvalued. The stock's GF Value™ is $65.80, compared to a current price of $87.55 — trading 33.1% above its estimated fair value. The current Dividend Yield % is 0.90%, which is 18% above median its 10-year median of 0.76 and 54.4% below the Medical Devices & Instruments industry median of 1.98. iRadimed's overall GF Score™ is 92/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For iRadimed (IRMD), the current Dividend Yield % is 0.90% as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is iRadimed (IRMD) Overvalued in 2026?
Based on GuruFocus' analysis, iRadimed stock appears to be overvalued.
The current stock price of $87.55 is trading 33.1% above its estimated GF Value™ of $65.80.
GuruFocus considers iRadimed to be Significantly Overvalued.
Key valuation signals for IRMD:
Dividend Yield %: 0.90% (18% above median its 10-year median of 0.76)
GF Value™: $65.80 vs. price of $87.55 (33.1% above fair value)
Industry Position: 54.4% below the Medical Devices & Instruments median (#247 of 316)
No single metric tells the full story. See the IRMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.
92GF Score
Get the complete analysis for IRMD
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IRMD has been successfully added to your 
